Molecular and Biochemical Genetics

From Iusmgenetics

(Difference between revisions)
(Objectives)
(qE5m7O Enjoyed every bit of your blog article.Thanks Again. Much obliged.)
 
(One intermediate revision not shown)
Line 1: Line 1:
-
==Molecular and Biochemical Genetics==
+
qE5m7O Enjoyed every bit of your blog article.Thanks Again. Much obliged.
-
 
+
-
===Objectives===
+
-
*Important terms:
+
-
**'''"Incomplete" dominance or "semi-dominant": homozygous individuals have a worse manifestation than heterozygous individuals (achondroplasia).'''
+
-
**"Distinct disorder": consistent clinical and radiological findings.
+
-
 
+
-
 
+
-
*Important concepts:
+
-
**Types of mutations:
+
-
***Missense: changed amino acid
+
-
***Nonsense: introduced stop codon
+
-
***Neutral / silent: no amino acid change
+
-
***Polymorphisms are a population term; it means 1% of the pop has it; it does not infer whether it causes disease or not
+
-
***RNA splicing: gain or loss of splice site
+
-
***Regulation mutation: affects gene regulation
+
-
***Indels: gain or loss of one or more bases; leads to frameshift if not a multiple of 3
+
-
***Repeat expansion: repeated segment (usually 3 bases) expands as nucleotide copy / repair mechanisms get hung up
+
-
**Haploinsufficiency:
+
-
**Dominant-negative effect:
+
-
 
+
-
 
+
-
*For individual diseases, know: clinical features, mode of inheritance, genes involved / gene defect, pathogenesis, treatment (sometimes)
+
-
 
+
-
===Review your fundamentals===
+
-
 
+
-
===Dominant Diseases===
+
-
*Dominant disease are defined as those manifested when only one allele is mutated.
+
-
**Recall that some diseases can be both dominant and negative because of allelic heterogeneity and locus heterogeneity.
+
-
*There are multiple ways a single allele (not both copies) can cause disease:
+
-
**''Qualitative effects'': the protein product gains a function.
+
-
**''Quantitative effects'': the protein product is broken.
+
-
**Combination of qualitative and quantitative.
+
-
**Others
+
-
*It is important to understand the disease pathogenesis in order to think wisely about treatment.
+
-
 
+
-
====[[Achondroplasia]]====
+
-
 
+
-
====[[Osteogenesis imperfecta]]====
+
-
 
+
-
====[[Ehlers Danlos Syndrome]]====
+
-
 
+
-
====[[Marfan syndrome]]====
+
-
 
+
-
====[[Familial Hypercholesterolemia]]====
+
-
 
+
-
===Recessive Diseases===
+
-
*Requires two mutant alleles to show the phenotype or disease state.
+
-
*Recall that a proband with a recessive disease usually has parents who are both carriers.
+
-
**However, there are exceptions: uniparental disomy, skewed lyonization.
+
-
*Recessive disorders usually result from a missing component of a pathway.
+
-
**Phenotype usually results from the accumulation of a precursor / metabolite.
+
-
 
+
-
====[[Homocysteinuria]]====
+
-
 
+
-
====[[Cystic Fibrosis]]====
+
-
 
+
-
====[[Hemochromatosis]]====
+
-
 
+
-
====[[Alpha-1-Anti-Trypsin deficiency]]====
+
-
 
+
-
====[[Phenylketonuria]]====
+
-
 
+
-
====[[Tay-Sachs Disease]]====
+
-
 
+
-
====[[Galactosemia]]====
+
-
 
+
-
====[[Maple Syrup Urine Disease]]====
+
-
 
+
-
====[[Biotinidase Deficiency]]====
+
-
 
+
-
===X-linked Diseases===
+
-
 
+
-
====[[Rett Syndrome]]====
+
-
 
+
-
====[[Lesch-Nyhan syndrome]]====
+
-
 
+
-
====[[Inherited Muscular Dystrophies]]====
+
-
 
+
-
===Newborn Screening===
+
-
*The following criteria for newborn screening assure that our screening has ''analytic validity'', ''clinical validity'', and ''clinical utility'':
+
-
**The disorder must be '''well defined'''.
+
-
**The disorder must be '''fairly high in population frequency''' (to justify the cost of newborn screening by the cost saved in care for the true-positives).
+
-
**The disorder must be '''poorly clinically detected early in life (assymptomatic)''' (otherwise it is more cost effective to let physicians identify the disease at newborn checkups).
+
-
**The disorder must be '''significant in morbidity / mortality if left untreated''' (otherwise we might start treating things that have little consequence).
+
-
**The disorder must be '''treatable such that there is an improved condition''' (lest we start adding anxiety to insult).
+
-
**The test must be '''rapid, inexpensive, specific AND sensitive over an entire population'''.
+
-
**The test must be '''acceptable and cost-effective'''.
+
-
**The test must be '''appropriately administered'''.
+
-
 
+
-
 
+
-
*Newborn screening is required by law on all infants
+
-
**A second test is required if the first screen is done prior to 48 hours
+
-
 
+
-
 
+
-
*In Indiana we screen for:
+
-
**Metabolic disorders:
+
-
***[[Phenylketonuria]]
+
-
***[[Galactosemia]]
+
-
***[[Maple Syrup Urine Disease]]
+
-
***[[Homocysteinuria]]
+
-
***[[Biotinidase Deficiency]]
+
-
**Endocrine disorders:
+
-
***Hypothyroidism
+
-
***Congenital Adrenal Hyperplasia
+
-
**Hemoglobinopathies:
+
-
***Sickle Cell Disease
+
-
**[[Cystic Fibrosis]]
+
-
*Using several methods: enzyme assays, radiommunoassays, electrophoresis, tandem mass spectrometry
+
-
 
+
-
====Pitfalls of Screening====
+
-
*False positives cause unecessary stress / anxiety and investigation / treatment.
+
-
*False negatives cause false security.
+
-
*Recalling the requirement that a screened disease must be "treatable" in some effective way, we see that prolonging the knowledge of a disease may be a form of harm if the disease cannot be treated.
+
-
*Medical procedures initiated because of screen results may be uncomfortable and unnecessary.
+
-
 
+
-
===General Molecular / Biochemical Pathogenesis Principles===
+
-
*Dominant diseases usually result from:
+
-
**Gain of abnormal function
+
-
**Haploinsufficiency
+
-
**Dominant-negative effects (think multi-subunit proteins)
+
-
**Combinations of these reasons
+
-
*Recall that dominant disease can be "incomplete" and thus have more severe phenotypes when presented as homozygous conditions.
+
-
*Recessive diseases usually result from:
+
-
**Loss of normal function
+
-
*Heterozygotes of recessive diseases (carriers) usually have enough wild-type gene product to function properly
+

Current revision as of 13:55, 8 March 2012

qE5m7O Enjoyed every bit of your blog article.Thanks Again. Much obliged.

Personal tools